1. Home
  2. NRT vs SRTS Comparison

NRT vs SRTS Comparison

Compare NRT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NRT

North European Oil Royality Trust

HOLD

Current Price

$7.85

Market Cap

59.0M

Sector

Energy

ML Signal

HOLD

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$4.47

Market Cap

67.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRT
SRTS
Founded
1975
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.0M
67.5M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
NRT
SRTS
Price
$7.85
$4.47
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
72.3K
71.4K
Earning Date
12-31-2025
02-04-2026
Dividend Yield
10.27%
N/A
EPS Growth
56.96
N/A
EPS
0.86
N/A
Revenue
$8,734,568.00
$35,609,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$29.12
P/E Ratio
$9.13
N/A
Revenue Growth
49.16
N/A
52 Week Low
$4.00
$3.03
52 Week High
$8.35
$9.08

Technical Indicators

Market Signals
Indicator
NRT
SRTS
Relative Strength Index (RSI) 67.65 68.20
Support Level $7.18 $3.65
Resistance Level $8.35 $4.64
Average True Range (ATR) 0.34 0.22
MACD 0.15 0.08
Stochastic Oscillator 78.09 83.84

Price Performance

Historical Comparison
NRT
SRTS

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: